Literature DB >> 6367675

Extractable immune complex in soluble substances from psoriatic scales.

F Kaneko, R Muramatsu, Y Takahashi, Y Miura.   

Abstract

Soluble substances of psoriatic scales (Pso-exts) were analysed immunologically to detect immune complex (IC) related to the immune reactions in psoriatic lesions and compared with extracts of scales from a patient with erythroderma due to pityriasis rubra pilaris (PRP-exts) as control. Immunoelectrophoretically IgG, IgA and C3 were detected in Pso-exists, but in PRP-exists only IgG was seen as immunological reactive substances. When analysed by Sephadex G-200 column chromatography, IgG and IgA eluates were found in Pso-exts with a molecular weight of more than 200,000 daltons. By Raji cell assay, the IgG and IgA eluates were shown to have IC characteristics and they were the IC composed of IgG-IgA, which was also confirmed using anti-IgG affinity chromatography. The IC seemed to be binding the epidermal proteins as antigen. These findings suggest that deposits of immunoglobulins and complement in the stratum corneum of psoriatic lesions are not just secondary to the underlying inflammation in the dermis but that the IC detected is related to the immune reactions in psoriatic lesions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367675     DOI: 10.1007/bf00412562

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  26 in total

1.  DNA-binding proteins of psoriatic scales. I. Isolation by affinity chromatography and characterisation by SDS slab gel electrophoresis.

Authors:  G Reimer; G Leonhardi; V Schwulera
Journal:  Arch Dermatol Res       Date:  1977-10-27       Impact factor: 3.017

2.  Immunofluorescent staining of keratin fibers in cultured cells.

Authors:  T T Sun; H Green
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

3.  An immunohistochemical analysis of the deposited immunoglobulins or fibrinogen in parakeratotic psoriatic horny layer and pemphigus skin lesions.

Authors:  S Kimura; T Nishikawa
Journal:  Arch Dermatol Res       Date:  1978-02-15       Impact factor: 3.017

4.  The natural mediator for PMN emigration in inflammation. V. The site of structural change in the chemotactic generation of immunoglobulin G by inflammatory SH-dependent protease.

Authors:  S Yammoto; M Nishiura; H Hayashi
Journal:  Immunology       Date:  1973-05       Impact factor: 7.397

5.  Effect of therapy on keratin polypeptide profiles of psoriatic epidermis.

Authors:  M J LeVine; N McGilvray; H P Baden
Journal:  Arch Dermatol       Date:  1980-09

6.  Demonstration of C3 cleavage product in leukotactic substances of scale extract from pustular psoriasis.

Authors:  H Tagami; S Ofuji
Journal:  Br J Dermatol       Date:  1977-01       Impact factor: 9.302

7.  A simplified method for studying fibrous proteins in psoriatic scales obtained by tape stripping.

Authors:  Y Kitajima; Y Tsuneda; S Mori; Y Okano; Y Nozawa
Journal:  Br J Dermatol       Date:  1982-06       Impact factor: 9.302

8.  Studies in immunodermatology. VII. Four-compartment system studies of IgG in stratum corneum and of stratum corneum antigen in biopsies of psoriasis and control dermatoses.

Authors:  S Jablonska; T P Chorzelski; M Jarzabek-Chorzelska; E H Beutner
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

9.  Keratin filaments of cultured human epidermal cells. Formation of intermolecular disulfide bonds during terminal differentiation.

Authors:  T T Sun; H Green
Journal:  J Biol Chem       Date:  1978-03-25       Impact factor: 5.157

10.  Immunopathology of psoriasis: a comparison with other parakeratotic lesions.

Authors:  V C Weiss; H van den Broek; S Barrett; D P West
Journal:  J Invest Dermatol       Date:  1982-03       Impact factor: 8.551

View more
  1 in total

1.  Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.

Authors:  A B Gottlieb; B Lifshitz; S M Fu; L Staiano-Coico; C Y Wang; D M Carter
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.